Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
THAP domain-containing protein 5 (THAP5) is a member of the THAP protein family, characterized by a conserved N-terminal THAP domain, approximately 90 amino acids in length, that mediates zinc-dependent sequence-specific DNA binding[1][2][3]. THAP5 appears to act as a transcriptional repressor in vitro and participates in the negative regulation of both cell cycle progression and transcription by RNA polymerase II[1][3]. It is mainly located within chromatin and nucleoplasm and likely contributes to chromatin modification and gene expression regulation[1][2][3]. While its precise biological role remains incompletely defined, THAP5, along with related THAP proteins, has been implicated in diverse cellular functions such as cell proliferation, apoptosis, chromatin modification, and transcriptional regulation[1][2][3]. Current data associate THAP5 with certain disease states, notably Townes-Brocks syndrome, dystonia, and possibly cancer, heart disease, and neurological disorders, but it is not a validated therapeutic drug target at present[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on THAP domain-containing protein 5 (THAP5).